ReviewLancet regional health. Americas2025

Could rituximab revolutionize multiple sclerosis treatment in Brazil? The missed opportunity for fewer relapses and lower costs.

Guilherme Diogo Silva et al.PubMed ↗Full text ↗Publisher ↗

No numbers read from the abstract.